ProfileGDS4718 / 222024_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 90% 82% 85% 88% 71% 71% 86% 88% 82% 83% 88% 78% 66% 74% 81% 81% 76% 75% 95% 88% 84% 82% 82% 87% 75% 84% 77% 87% 74% 82% 80% 89% 86% 77% 69% 78% 88% 86% 82% 78% 69% 80% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4284885
GSM549102patient 115, normal, homogenized [OPG study]9.2246290
GSM549104patient 119, normal, homogenized [OPG study]8.130582
GSM549108patient 138, normal, homogenized [OPG study]8.4335485
GSM549119patient 077, normal, homogenized [OPG study]8.8077188
GSM549133patient 032, cancer, homogenized [OPG study]7.0720271
GSM549139patient 042, cancer, homogenized [OPG study]6.9494871
GSM549099patient 107, normal, homogenized [OPG study]8.4683886
GSM549109patient 139, normal, homogenized [OPG study]8.8342788
GSM549110patient 046, normal, homogenized [OPG study]8.095982
GSM549114patient 063, normal, homogenized [OPG study]8.3463783
GSM549122patient 082, normal, homogenized [OPG study]8.9508488
GSM549134patient 033, cancer, homogenized [OPG study]7.6496478
GSM549136patient 036, cancer, homogenized [OPG study]6.6002866
GSM549140patient 044, cancer, homogenized [OPG study]7.3148774
GSM549111patient 047, normal, homogenized [OPG study]8.0553381
GSM549113patient 057, normal, homogenized [OPG study]8.0755281
GSM549132patient 031, cancer, homogenized [OPG study]7.4699776
GSM549137patient 038, cancer, homogenized [OPG study]7.3925375
GSM549142patient 047, cancer, homogenized [OPG study]9.7949795
GSM549100patient 110, normal, homogenized [OPG study]8.7829388
GSM549107patient 135, normal, homogenized [OPG study]8.3750284
GSM549115patient 068, normal, homogenized [OPG study]8.2405682
GSM549116patient 072, normal, homogenized [OPG study]8.1609382
GSM549120patient 078, normal, homogenized [OPG study]8.7744687
GSM549131patient 030, cancer, homogenized [OPG study]7.4092775
GSM549118patient 074, normal, homogenized [OPG study]8.314784
GSM549129patient 027, cancer, homogenized [OPG study]7.5442877
GSM549123patient 088, normal, homogenized [OPG study]8.717787
GSM549124patient 006, cancer, homogenized [OPG study]7.1393974
GSM549126patient 015, cancer, homogenized [OPG study]8.1096882
GSM549128patient 025, cancer, homogenized [OPG study]7.9562680
GSM549103patient 117, normal, homogenized [OPG study]8.9895389
GSM549117patient 073, normal, homogenized [OPG study]8.6597686
GSM549138patient 041, cancer, homogenized [OPG study]7.5823677
GSM549141patient 045, cancer, homogenized [OPG study]6.8206469
GSM549130patient 028, cancer, homogenized [OPG study]7.6175678
GSM549101patient 111, normal, homogenized [OPG study]8.7784988
GSM549105patient 128, normal, homogenized [OPG study]8.4890186
GSM549106patient 134, normal, homogenized [OPG study]8.2567982
GSM549112patient 048, normal, homogenized [OPG study]7.6738178
GSM549125patient 011, cancer, homogenized [OPG study]6.7876469
GSM549127patient 024, cancer, homogenized [OPG study]7.8810380
GSM549135patient 035, cancer, homogenized [OPG study]7.7945878